Her new show opens this weekend and runs through Oct. 20
The painter Mary Lovelace O’Neal has returned to the San Francisco Museum of Modern Art for the first time in 45 years. The solo exhibition “New Work: Mary Lovelace O’Neal” opened Saturday and runs through Oct. 20.
Lovelace O’Neal moved to San Francisco in the 1970s and later joined the faculty at University of California, Berkeley, where in 1985 she became the first African American professor awarded tenure in the Department of Art Practice. She was named chair of the department in 1999, and professor emerita in 2006. She now splits her time between Oakland and Mexico.
Ex // Top Stories Ballot measure to spur housing conversions downtown passes Majority of voters supported Mayor London Breed’s ballot measure to boost the downtown economy Colors shout out of the blackness in a shock of saturation in each painting. Teal, red, periwinkle, pink and sandy whites mix and overlap to create a sense of motion. Lovelace O’Neal has likened painting with color to “dancing with the paint.” Her canvases are all 7 feet tall and encourage an active viewing experience.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New SFMOMA exhibit showcases artists with disabilitiesAn Oakland nonprofit is doing important work to champion Bay Area artists with disabilities. The public will soon have an opportunity to enjoy their art as part of a new exhibit at SFMOMA.
Read more »
FDA says toxic chemicals in pizza boxes and popcorn bags no longer used in food packagingBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
1st OTC birth control pill expected to be available as early as month's endBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
FDA approves Wegovy to reduce heart attack and stroke riskBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
In an unusual move, FDA postpones approval decision for Lilly’s Alzheimer’s drugBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
FDA says it's found lead in several more cinnamon products in the U.S.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »